Pacific Smiles Group Limited (ASX: PSQ) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Pacific Smiles Group Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Pacific Smiles Group Limited (ASX: PSQ)
Latest News

No posts found.

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
24 Sep 2024 $0.0325 100.00% Final 10 Oct 2024
21 Mar 2024 $0.0210 100.00% Interim 05 Apr 2024
21 Sep 2023 $0.0227 100.00% Final 09 Oct 2023
22 Mar 2023 $0.0035 100.00% Interim 06 Apr 2023
24 Mar 2021 $0.0240 100.00% Interim 09 Apr 2021
18 Mar 2020 $0.0240 100.00% Interim 01 May 2020
18 Sep 2019 $0.0350 100.00% Final 04 Oct 2019
18 Mar 2019 $0.0230 100.00% Interim 05 Apr 2019
19 Sep 2018 $0.0380 100.00% Final 05 Oct 2018
16 Mar 2018 $0.0230 100.00% Interim 04 Apr 2018
14 Sep 2017 $0.0000 100.00% Final 03 Oct 2017
15 Sep 2016 $0.0350 100.00% Final 04 Oct 2016
15 Mar 2016 $0.0200 100.00% Interim 01 Apr 2016

PSQ ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Brent Cubis Non-Executive Director Oct 2024
Mr Cubis was Chief Financial Officer at several healthcare and multisite businesses including Cochlear Ltd, National Home Doctor Service Ltd, Fitness First Ltd and Chris O'Brien Lifehouse Ltd. Following his executive career, he has held several non-executive director roles and is currently a Non-Executive Director on the boards of AI Media, ARN Media, Silverchain Group and Austal Ltd and is the Chair of the Audit & Risk Committee for each of these companies. In his spare time, he sits on the board of not-for-profit Canteen, an organization in Australia dedicated to providing tailored support for young people impacted by cancer. He is Chairman of the Risk Committee.
Mr Steven Rubic Non-Executive Director May 2023
Mr Rubic has experience as a Non-Executive Director and is currently Deputy Chair of InvoCare funerals & crematoria business, a Non-Executive Director of the Mater Hospitals Group, and Catholic Healthcare Limited governing its retirement living & residential aged care business. Previously, Steven has chaired organizations including the NSW Private Hospitals Association and Monte Sant' Angelo College. His board leadership extends to roles at the Garvan Institute of Medical Research, the Chris O'Brien Lifehouse, the Macquarie University Council and the Health Industry Superannuation Plan. With over 25 years of executive leadership, Steven has held CEO positions at St Vincent's & Mater Health Sydney, I-MED Radiology Network and Healthscope. He is a member of the Risk Committee.
Ms Tara Hariharan Non-Executive Director Dec 2024
Ms Hariharan is an Investment Manager at Genesis Capital. Prior to this, she was a management consultant at Bain & Company, and has worked across the healthcare, financial services, and not-for-profit sectors. Tara is currently the Director of Genesis Capital portfolio company Impression Dental Group.
Dr Michael Caristo Non-Executive ChairmanNon-Executive Director Dec 2024
Dr Caristo is a Founding Partner of Genesis Capital. Before establishing Genesis Capital, he was an investment professional at an Australian private equity firm and served as a non-executive director on several portfolio businesses. Dr Caristo began his career at Bain & Company, where he specialized in transaction services. He is also a contributor in the field of stem-cell research. Michael is currently director of Genesis Capital portfolio companies Sana Health Group, Impression Dental, Crux Biolabs, Syntro and Momentum Research as well as a former director of Avance, Agilex and SmartClinics. He is a member of the Risk Management Committee.
Mr Christopher(Chris) Yoo Non-Executive Director Dec 2024
Mr Yoo is a Founding Partner of Genesis Capital. Prior to Genesis Capital, he was a Partner, member of the investment committee and Principal at globally recognized private equity firms. Chris has held numerous directorships and board roles at various companies and currently serves as a Director of Genesis Capital portfolio companies General Homecare, Therapy Pro, HealthBright, Lifecare Consultants, and Southern Cross Support Services. He is a Member of the Risk Management Committee.
Mr Euh(David) Hwang Company Secretary Feb 2025
-
Ms Elizabeth Spooner Company Secretary Feb 2025
-
Martin White Chief Financial Officer
-
Euh(David) Hwang Company Secretary
-
Elizabeth Spooner Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Beam Dental Bidco Pty Ltd 144,273,813 89.27%
Alison Jane Hughes 16,178,947 10.01%
Mr Allan Graeme Roberts 252,124 0.16%
HSBC Custody Nominees (Australia) Limited 166,607 0.10%
BNP Paribas Nominees Pty Ltd (IB Au Noms Retail Client) 93,895 0.02%
Annabash Pty Limited (The Annabash Investment A/C) 44,800 0.03%
Citicorp Nominees Pty Limited 27,327 0.02%
Maralda Pty Limited 15,385 0.01%
Mr Peter Lawrence Gisz 15,369 0.01%
HSBC Custody Nominees (Australia) Limited A/C 2 15,193 0.01%
Mr Simon Richard Ward & Miss Collette Keenan (Ward Keenan S/F A/C) 14,040 0.01%
Mr Anthony Michael Donato & Mrs Palmina Donato (Donato Executive SF A/C) 13,500 0.01%
Mr Ross John Hughes 13,094 0.01%
Miss Leanne E Clark 12,820 0.01%
A & H Nominees Pty Ltd (HJ Superannuation Fund A/C) 12,486 0.01%
Mr Matthew Learn 11,230 0.01%
Warbont Nominees Pty Ltd (Unpaid Entrepot A/C) 10,138 0.01%
Ms Petrina Fawcett 9,348 0.01%
Limits Pty Ltd (Duncan Gamble Family A/C) 9,146 0.01%
Kayday Pty Ltd (Kayday Super Fund A/C) 8,768 0.01%

Profile

since

Note